A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Rufinamide
Test Code16296
Alias/See Also
LAB00954
CPT Codes
80210<br><strong>This test is not available for New York patient testing.</strong>
Preferred Specimen
1 mL serum collected in a red-top tube (no gel)
Patient Preparation
A trough specimen is preferred. Collect sample within 1 hour prior to next dose.
Minimum Volume
0.5 mL
Other Acceptable Specimens
Plasma collected in: EDTA (lavender-top) tube
Transport Container
Transport tube
Transport Temperature
Room temperature
Specimen Stability
Room temperature: 7 days
Refrigerated: 30 days
Frozen: 30 days
Refrigerated: 30 days
Frozen: 30 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Serum separator tube (SST)
Methodology
Chromatography/Mass Spectrometry
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
This test is not available for New York patient testing.
Setup Schedule
Wed, Sat
Report Available
3-6 days
Reference Range
Maintenance therapy with 45 mg/kg (approximately 1600 mg) daily Rufinamide resulted in plasma concentrations ranging from 5.0-55.0 mcg/mL.
Clinical Significance
Rufinamide is an antiepileptic indicated for adjunctive treatment of seizures associated with Lennox-Gastaut syndrome in children and adults. As multiple antiepileptics may be administered, it may be important to (1) optimize therapy, (2) monitor compliance, and (3) avoid toxicity.
Performing Laboratory
med fusion |
2501 South State Hwy 121, Suite 1100 |
Lewisville, TX 75067-8188 |